Level of the expression of VEGF-A, B, C, D and their receptors (FLT-1, KDR and FLT-4) and its correlation with prognosis in patients with colorectal cancer

International Journal of Cancer Research

Volumn 2, Issue 1, 2006, Pages 31-41

  Rmali, Khaled A ^a   Puntis, Malcolm C A ^a   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Angiogenesis; Colon cancer; Dukes stage; VEGFs

Indexed keywords

ANGIOGENIC FACTOR; RNA; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CANCER TISSUE; CLINICAL ARTICLE; COLON CANCER; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE AMPLIFICATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; LAMINA PROPRIA; LYMPH NODE METASTASIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE;

EID: 33646388665     PISSN: 18119727     EISSN: 18119735     Source Type: Journal    
DOI: 10.3923/ijcr.2006.31.41     Document Type: Article

References (49)

1. American Joint Committee on Cancer Staging Colon And Rectum, 1988.
2. America Joint Committee on Cancer Staging AJCC Cancer Staging Manual, 1997. Color and rectum. 5th Edn.
3. Andre, T, L. Kotelevets, J.C. Vaillant, A.M. Coudray, L. Weber, S. Prevot, R. Pare, C. Gespach and E. Chastre, 2000. VEGF, VEGF-B, VEGF-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa, Intl. J. Cancer, 86: 174-181.
4. Bricknell, R. and A.L. Harris, 1991. Nove; Growth regulatory factors and tumour angiogenesis. Eur. J. Cancer, 27: 781-785.
5. Chapuis, P.H., O.F. Dent, R. Fisher, R.C. Newland, M.T. Pheils and E. Smyth, 1985. A multivariate analysis of clinical and pathological variables in prognosis after rescetion of large bowel cancer. Br. J. Cancer, 72: 1424-1429.
6. Chodac, G.W., C. Haudenschild, R.F. Gittes and J. Folkman, 1980. Angiogeneic activity as a marker of neoplasia and preneoplasia in lesions of the human bladder. Ann. Surg., 192: 762-771.
7. Crystal, R.G., 1999. In vivo and ex vivo gene therapy strategies to treat tumors using adenovirus gene transfer vectors. Cancer Chemother Pharmacol., 43: s90-99.
8. Dukes, C.E. and H.J.R. Bussey, 1958. The spread of rectal cancer and its effect on prognosis. Br. J. Cancer, 12: 309-320.
9. Dvorak, H.F., J.A. Nagy, D. Feng, L.F. Brown and M.D. Vorak, 1995. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Am. J. Pathol. Gastroenterol., 146: 1029-1039.
10. Dvorak, H.F., J.A. Nagy, D. Feng, L.F. Brown and M. Dvorak, 1999. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr. Top. Microbiol. Immunol., 237: 97-132.
11. Feldman, A. L. and S.K. Libutti, 2000. Progress in antiangiogenic gene therapy of cancer. Cancer, 89: 1181-1194.
12. Ferrara, N., 1996. Vascular endothelial growth factor. Eur. J. Cancer, 32A: 2413-2422.
13. Fielding, L.P., R.K. Phillips, J.S. Fry and R. Hittinger, 1986. Prediction of outcome after curative resection for large bowel cancer. Lancet, II: 904-907.
14. Furudoi, A., S. Tanaka, K. Haruma, Y. Kitadai, M. Yoshihara, K. Chayama and F. Shimamoto, 2002. Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma. Oncology, 62: 157-166.
15. Grimmond, S., J. Lagercrantz, C. Drinkwater, G. Silins, S. Townson and P. Pollock et al., 1996. Cloning and characterization of a novel human gene related to vascular endothelial growth factor. Genome Res, 6: 124-131.
16. Hanrahan, V., M.J. Currie, S.P. Gunningham, H.R. Morrin, P.A. Scott, B.A. Robinson, S.B. Fox, 2003. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. J. Pathol., 200: 183-194.
17. Hiratsuks, S., O. Minowo, J. Kuno, T. Noda and M. Shibuya, 1998. FLT-1 lacking the tyrosin kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl. Acad. Sci., USA, 95: 9349-9354.
18. Houck, K.A., N. Ferrara, J. Winer, G. Cachianes, B. Li and D.W. Leung, 1991. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol., 5: 1806-1814.
19. International Union Against Cancer Colon and Rectum., 1997. 5th Edn.
20. Jia, Y.T., Z.X. Li, Y.T. He, W. Liang, H.C. Yang and H.J. Ma, 2004. Expression of vascular endothelial growth factor-C and the relationship between lymphangiogenesis and lymphatic metastasis in colorectal cancer. World J. Gastroenterol., 10: 3261-3263.
21. Jiang, W.G., A. Douglas-Jones and R.E. Mansel, 2003a. Level of expression of PPAR-gamma and its co-activator (PPAR-GCA) in human breast cancer. Intl. J. Cancer, 106: 52-757.
22. Jiang, Wg., G. Watkins, J. Lane, A. Douglas-Jones, G.H. Cunnick, M. Mokbel and R.E. Mansel, 2003b. Prognostic value of Rho familty and and rho-GDIs in breast cancer. Clin. Cancer Res., 9: 6432-6440.
23. Joukov, V., K. Pajusola, A. Kaipainen, D. Chilov, I. Lahtinen, E. Kukk, O. Sakseal, N. Kalkkinen and K. Alitalo, 1996. A novel vascular endothelial growth factor, VEGF-C is ligand for the FLT4(VEGFR-3)and KDR(VEGFR-2) receptor tyrosin kinase. Embo. J., 15: 290-298.
24. Kaio, E., S. Tanaka, Y. Kitadai, M. Sumii, M. Yoshihara, K. Haruma and K. Chayama, 2003. Clinical significance of angiogenic factor expression at the deepest invasive site of advanced colorectal carcinoma. Oncology, 64: 61-73.
25. Kang, S.M., K. Maeda, N. Onoda, Y.S. Chung, B. Nakata, Y. Nishiguchi and M. Sowa, 1997. Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis. Intl. J. Cancer, 74: 502-507.
26. Kawakami, M., T. Furahata, Y. Kimura, K. Yamaguchi, F. Hata, K. Sasaki and K. Hirata, 2003a. Expression analysis of vascular endothelial growth factors and their relationships to lymph node metastasis in human colorectal cancer. J. Exp. Clin. Cancer Res., 22: 229-237.
27. Kawakami, M., T. Furuhata, Y. Kimura, K. Yamaguchi, F. Hata, K. Sasaki and K. Hirata, 2003b. Quantification of vascular endothelial growth factor-C and its receptor-3 messenger RNA with real-time quantitative polymerase chain reaction as a predictor of lymph node metastasis in human colorectal cancer. Surgery, 133: 300-308.
28. Kawakami, M., Y. Yanai, F. Hata and K. Hirata, 2005. Vascular endothelial growth factor C promotes lymph node metastasis in a rectal cancer orthotopic model. Surg Today, 35: 131-138.
29. Kazama, S., J. Kitayama, T. Watanabe and H. Nagawa, 2004. Expression pattern of vascular endothelial growth factor-C in human colorectal normal mucosa and neoplastic mucosa. Hepatogastroenterology, 51: 391-395.
30. Kerbel, R. and J. Folkman, 2002. Clinical translation of angiogenesis inhibitors. Nat. Rev. Cancer, 2: 727-739.
31. Khorana, A.A., C.K. Ryan, C. Cox, S. Eberly and D.M. Sahasrabudhe, 2003. Vascular endothelial growth factor, CD68 and epidermal growth factor receptor expression and survival in patients with Stage II and Stage III colon carcinoma: a role for the host response in prognosis. Cancer, 97: 960-968.
32. Kieser, A., H.A. Weich, G. Brandner, D. Marme and W. Koloch, 1994. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor. Oncogen, 9: 963-969.
33. Lee, J.C., N.H. Chow, S.T. Wang and S.M. Huang, 2000. Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients. Eur. J. Cancer, 36: 748-753.
34. Leung, D.W., G. Cachianes, W.J. Kuang, D.V. Goeddel and N. Ferrara, 1989. Vascular endothelial growth factor is a secreted angiogenic mitogen. Sciences, 246: 1306-1309.
35. Mattei, M.G., J.P. Borg, O. Rosent, D. Marme and D. Birnbaum, 1996. Assignment of Vascular Endothelial Growth Factor (VEGF) and Placenta Growth Factor (PIGF)genes to human chormosomes 6p12-p2l and 14q24-q31 regions,respectively. Genomics, 32: 168-169
36. Neufeld, G., S. Tessler, H. Gitay-Goren, T. Cohen, B.Z. Levi, T. Cohen, S. Gengrinovitch and Z. Poltorak, 1999. Vascular Endothelial Growth Factor (VEGF) and its receptors. Faseb J., 13: 9-22
37. Olofsson, B., K. Pajusola, G. Von Euler, D. Chilov, K. Alitalo and U. Eriksson, 1996. Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform. J. Biol. Chem., 271: 19310-19317.
38. Onogawa, S., Y. Kitadai, S. Tanaka, T. Kuwai, S. Kimura and K. Chayama, 2004a. Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma. Cancer Sci., 95: 32-39.
39. Onogawa, S., Y. Kitadai, S. Tanaka, T. Kuwai, T. Kuroda and K. Chayama, 2004b. Regulation of vascular endothelial growth factor (VEGF)-C and VEGF-D expression by the organ microenvironment in human colon carcinoma. Eur. J. Cancer, 40: 1604-1609.
40. Papetti, M. and I.M. Herman, 2002. Mechanisms of normal and tumor-derived angiogenesis. Am. J. Physiol. Cell Physiol., 282: C947-C970.
41. Petri, S., L. Athina, H. Paivi, J. Hilkka, E. Bernd, A. Karin, E. Gabriel von, E. Ulf, A. Kari and J. Heikki, 1998. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am. J. Pathol., 153: 103-108.
42. Senger, D.R., S.J. Galli, M. Dvorak a, C.A. Perruzzi, V.S. Harvey and H.F. Dvorak, 1983. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Sci., 219: 983-985.
43. Senger, D.R., D.E. Van, L. Water, L.F. Brown, J.A. Nagy, K.T. Yeo, B. Barse, R.W. Jackman, A.M. Dovark and H.F. Dovark, 1993. Vascular peremability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev., 12: 203-224.
44. Stacker, S.A., C. Caesar, M.E. Baldwin, G.E. Thomton, R.A. Williams, R. Prevo, D.G. Jackson, S. Nishikawa, H. Kubo and M.G. Achen, 2001. VEGF-D promtes the metastasis spread of tumor cells via lymphatics. Nat. Med., 7: 186-191.
45. Tischer, E., R. Mitchell, T. Hartman, M. Silva, D. Gospodarowicz, J.C. Fiddes and J.A. Abraham, 1991. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem., 266: 11947-11954.
46. Tokunaga, T., H. Kijima, Y. Oshika, Y. Fukushima, Y. Abe, Y. Ohnishi, H. Yamazaki, T. Tsuchida, H. Makuuchi, N. Tamaoki, Y. Ueyama and M. Nakamura, 1998. Aberrant isoform of vascular endothelial growth factor 189 expression is correlated with xenotransplantability of human esophageal cancer. Oncol. Rep., 5: 1115-1118.
47. Veilkkola, T., M. Karkkainen, L. Claesson-Welsh and K. Alitalo, 2000. Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res., 60: 203-212.
48. Werther, K., I.J. Christensen, N. Brunner and H.J. Nielsen, 2000. Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group. Eur. J. Surg. Oncol., 26: 657-662.
49. Winawer, S.J., R.H. Fletcher, L. Miller, F. Godlee, C. Mulrow, S.H. Woolf S.N. Glick, T.G. Ganiats, J.H. Bond, L. Rosen, J.G. Zapka, S.J. Olsen, F.M. Giardiello and J.E. Sisk, 1997) Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology, 112: 594-642.